Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Harnessing big data — it’s challenging, but it can be done
Posted on February 12th, 2018 by Christy J. Wilson in Pharma R&D
Today’s big data has the power to drive innovation in ways that the pharmaceutical industry could previously only dream of. Yet harnessing that power comes with an equally sizable challenge: it will require an enormous shift in how research is performed. Continue reading “Harnessing big data — it’s challenging, but it can be done” »
Quantitative Proteomics: A Major Piece in the Precision Medicine Puzzle
Posted on December 22nd, 2017 by Betsy Davis in Pharma R&D
Our genetic make-up, where we live and how we live, are all important factors to consider when we are dealing with disease. For a very long time, medicine has mostly been designed to treat the sickness without much thought to the individual who has it. Continue reading “Quantitative Proteomics: A Major Piece in the Precision Medicine Puzzle” »
How Pharma Can Make the Most of Gene Tech CRISPR
Posted on December 18th, 2017 by Matthew Clark in Pharma R&D
The gene-editing technology CRISPR, which stands for ‘clustered regularly interspaced short palindromic repeats,’ is one of today’s most-talked-about scientific innovations. In just a few years, it’s gone from being a barely known entity to becoming a regular presence in scientific literature. Continue reading “How Pharma Can Make the Most of Gene Tech CRISPR” »
Seeking Other Perspectives to Tease Out New Innovations
Posted on November 22nd, 2017 by Betsy Davis in Pharma R&D
On October 24, Astellas Oncology announced the five finalists in its C3 Prize competition, chosen from over 160 entrants who submitted their ideas on how to improve the cancer care experience through non-medicine innovations. Continue reading “Seeking Other Perspectives to Tease Out New Innovations” »
